ZA90336B - Platinum pharmaceutical agents - Google Patents

Platinum pharmaceutical agents

Info

Publication number
ZA90336B
ZA90336B ZA90336A ZA90336A ZA90336B ZA 90336 B ZA90336 B ZA 90336B ZA 90336 A ZA90336 A ZA 90336A ZA 90336 A ZA90336 A ZA 90336A ZA 90336 B ZA90336 B ZA 90336B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical agents
platinum
platinum pharmaceutical
agents
pharmaceutical
Prior art date
Application number
ZA90336A
Other languages
English (en)
Inventor
Abdolhossen Talebian
Dianna C Green
Philip S Schein
Original Assignee
Univ Georgetown
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Georgetown filed Critical Univ Georgetown
Publication of ZA90336B publication Critical patent/ZA90336B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00—Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086—Platinum compounds
    • C07F15/0093—Platinum compounds without a metal-carbon linkage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA90336A 1989-01-17 1990-01-17 Platinum pharmaceutical agents ZA90336B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29736889A 1989-01-17 1989-01-17
US07/301,773 US4946954A (en) 1989-01-17 1989-01-26 Platinum pharmaceutical agents

Publications (1)

Publication Number Publication Date
ZA90336B true ZA90336B (en) 1990-10-31

Family

ID=26970120

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA90336A ZA90336B (en) 1989-01-17 1990-01-17 Platinum pharmaceutical agents

Country Status (13)

Country Link
US (1) US4946954A (xx)
EP (1) EP0462980A4 (xx)
JP (1) JP2771326B2 (xx)
AU (2) AU5039490A (xx)
CA (1) CA2045120A1 (xx)
HU (1) HUT59690A (xx)
IL (1) IL93090A (xx)
NO (1) NO180588C (xx)
NZ (1) NZ232134A (xx)
PH (1) PH26424A (xx)
RU (1) RU2074861C1 (xx)
WO (1) WO1990008157A1 (xx)
ZA (1) ZA90336B (xx)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5041581A (en) * 1985-10-18 1991-08-20 The University Of Texas System Board Of Regents Hydrophobic cis-platinum complexes efficiently incorporated into liposomes
US5384127A (en) * 1985-10-18 1995-01-24 Board Of Regents, The University Of Texas System Stable liposomal formulations of lipophilic platinum compounds
WO1990012018A1 (en) * 1989-04-04 1990-10-18 Daikin Industries, Ltd. New fluorocarbon platinum complexes
US5871710A (en) * 1992-09-04 1999-02-16 The General Hospital Corporation Graft co-polymer adducts of platinum (II) compounds
AU2701395A (en) * 1994-06-27 1996-01-19 General Hospital Corporation, The Graft co-polymer adducts of platinum (ii) compounds
ATE246696T1 (de) * 1995-05-09 2003-08-15 Kreatech Biotech Bv Verfahren zur herstellung von linkern zwischen markierungsgruppen und bio-organischen molekülen auf der basis von platin für die markierung von bio-organischen molekülen zur entdeckung interessanter biologischer substanzen
US5843475A (en) * 1996-12-06 1998-12-01 Board Of Regents, The University Of Texas System Delivery and activation through liposome incorporation of diaminocyclohexane platinum (II) complexes
US6235776B1 (en) 1998-11-12 2001-05-22 Cell Pathways, Inc. Method for treating a patient with neoplasia by treatment with a paclitaxel derivative
US6235782B1 (en) 1998-11-12 2001-05-22 Rifat Pamukcu Method for treating a patient with neoplasia by treatment with a platinum coordination complex
AU775373B2 (en) 1999-10-01 2004-07-29 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
AU2006222657B2 (en) * 2000-01-04 2009-01-15 Access Pharmaceuticals, Inc. N,O-amidomalonate platinum complexes
US7166733B2 (en) * 2000-01-04 2007-01-23 Access Pharmaceuticals, Inc. O,O'-Amidomalonate and N,O-Amidomalonate platinum complexes
KR100729015B1 (ko) * 2000-01-04 2007-06-14 어섹스 팔마큐티칼스 인코포레이티드 Ｎ,ｏ-아미도말로네이트 백금 착화합물
KR20040074857A (ko) * 2003-02-19 2004-08-26 학교법인 이화학당 Ｎ-치환 아미노디카복실산의 백금(ⅱ) 착물 및 그 제조방법
KR100499340B1 (ko) * 2003-04-29 2005-07-04 학교법인 이화학당 암 조직 선택성과 생분해성을 갖는폴리포스파젠-백금(ⅱ)착물 복합체 항암제 및 그 제조방법
WO2006091790A1 (en) * 2005-02-23 2006-08-31 Xenoport, Inc. Platinum-containing compounds exhibiting cytostatic activity, synthesis and methods of use
RU2319491C1 (ru) 2006-07-12 2008-03-20 Бадулин Николай Александрович Противоопухолевая, антибактериальная и антивирусная фармацевтическая композиция (ее варианты)
US8389506B2 (en) * 2007-12-07 2013-03-05 Prana Biotechnology Ltd. Compounds for therapy and diagnosis
ES2704303T3 (es) 2010-08-24 2019-03-15 Dana Farber Cancer Inst Inc Procedimientos para la predicción de una respuesta contra el cáncer
EP3693473A1 (en) 2011-06-17 2020-08-12 Myriad Genetics, Inc. Methods and materials for assessing allelic imbalance
CN102863474A (zh) 2011-07-09 2013-01-09 陈小平 一类治疗细胞增殖性疾病的铂化合物、其制备方法和应用
CN102993239A (zh) * 2011-09-19 2013-03-27 陈小平 离去基团含氨基或烷胺基的丁二酸衍生物的铂类化合物
CN103703011B (zh) * 2011-12-07 2016-06-22 北京市丰硕维康技术开发有限责任公司 一类离去基团是含氨基或烷氨基的羟基酸衍生物的铂类化合物及其制备方法和应用
AU2012358244A1 (en) 2011-12-21 2014-06-12 Myriad Genetics, Inc. Methods and materials for assessing loss of heterozygosity
CA3080441A1 (en) 2012-02-23 2013-09-06 The Children's Hospital Corporation Methods for predicting anti-cancer response
NZ630278A (en) 2012-06-07 2017-02-24 Inst Curie Methods for detecting inactivation of the homologous recombination pathway (brca1/2) in human tumors
WO2014160080A1 (en) 2013-03-14 2014-10-02 Children's Medical Center Corporation Cancer diagnosis, treatment selection and treatment
EP3007709B1 (en) 2013-06-14 2021-12-08 Akamara Therapeutics, Inc. Lipid-based platinum compounds and nanoparticles
WO2014203691A1 (ja) * 2013-06-18 2014-12-24 株式会社ヤクルト本社 白金錯体を含有する新規医薬
WO2015086473A1 (en) 2013-12-09 2015-06-18 Institut Curie Methods for detecting inactivation of the homologous recombination pathway (brca1/2) in human tumors
EP3686288B1 (en) 2014-08-15 2023-03-08 Myriad Genetics, Inc. Methods and materials for assessing homologous recombination deficiency
CN107847457B (zh) 2015-05-19 2022-07-05 阿卡马拉医疗公司 制备超分子铂基化合物的方法
US20210137874A1 (en) * 2017-03-22 2021-05-13 The Regents Of The University Of California Modified platinum compounds and therapeutic uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4115418A (en) * 1976-09-02 1978-09-19 Government Of The United States Of America 1,2-diaminocyclohexane platinum (ii) complexes having antineoplastic activity
US4284579A (en) * 1979-07-17 1981-08-18 The United States Of America As Represented By The Of The Department Of Health & Human Services (N-Phosphonacetyl-L-aspartato)(1,2-diaminocyclchexane)platinum(II) or alkali metal salt
JPS57123198A (en) * 1981-01-23 1982-07-31 Shionogi & Co Ltd Novel platinum complex
JPS5921697A (ja) * 1982-06-24 1984-02-03 Yoshinori Kitani 新規な白金錯体
US4673754A (en) * 1983-10-14 1987-06-16 Inco Alloys International, Inc. Platinum and palladium complexes
IL73337A (en) * 1984-10-28 1988-09-30 Yissum Res Dev Co Antitumor steroid-platinum complexes and method for the preparation thereof
US4587331A (en) * 1984-12-17 1986-05-06 American Cyanamid Company Platinum complexes of polyhydroxylated alkylamines and 2-polyhydroxylated alkyl-1,2-diaminoethanes
US4882447A (en) * 1987-02-20 1989-11-21 Tanabe Seiyaku Co., Ltd. Novel organic platinum complex and process for the preparation thereof
ATE87314T1 (de) * 1987-07-17 1993-04-15 Univ Georgetown Platin-arzneimittel.

Also Published As

Publication number Publication date
AU674185B2 (en) 1996-12-12
AU5479294A (en) 1994-03-31
NZ232134A (en) 1992-09-25
HUT59690A (en) 1992-06-29
US4946954A (en) 1990-08-07
IL93090A0 (en) 1990-11-05
NO180588C (no) 1997-05-14
NO912732D0 (no) 1991-07-11
CA2045120A1 (en) 1990-07-18
WO1990008157A1 (en) 1990-07-26
JPH04502767A (ja) 1992-05-21
JP2771326B2 (ja) 1998-07-02
PH26424A (en) 1992-07-15
RU2074861C1 (ru) 1997-03-10
NO180588B (no) 1997-02-03
EP0462980A1 (en) 1992-01-02
IL93090A (en) 1995-10-31
AU5039490A (en) 1990-08-13
EP0462980A4 (en) 1992-03-11
NO912732L (no) 1991-07-11

Similar Documents

Publication Publication Date Title
ZA90336B (en) Platinum pharmaceutical agents
ZA908157B (en) Pharmaceutical phenylpyridone derivatives
GR900100679A (en) Novel pharmaceutical use
EP0423707A3 (en) Platinum complexes
ZA902519B (en) Pharmaceutical formulations
GB2232891B (en) Pharmaceutical composition
ZA906128B (en) Pharmaceutical formulation
CS343490A3 (en) Pharmaceutical
GB8900228D0 (en) Pharmaceutical use
GB8904260D0 (en) New pharmaceutical use
GB8904257D0 (en) New pharmaceutical use
GB8918964D0 (en) Novel pharmaceutical use
IE900168L (en) Platinum pharmaceutical compounds
GB8600066D0 (en) Pharmaceutical agents
GB8605750D0 (en) Pharmaceutical agents
GB8919592D0 (en) Pharmaceutical formulation
GB8923046D0 (en) Pharmaceutical formulation
GB8926945D0 (en) Pharmaceutical formulation
IE893119L (en) Pharmaceutical formulation
GB8919596D0 (en) Pharmaceutical formulation
GB8919593D0 (en) Pharmaceutical formulation
ZA902089B (en) Pharmaceutical formulation
GB8909924D0 (en) Pharmaceutical formulation
GB8902809D0 (en) Pharmaceutical formulation
GB8919594D0 (en) Pharmaceutical formulation